NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE278137 Query DataSets for GSE278137
Status Public on Nov 12, 2024
Title Microglia regulate cortical remyelination via ΤNFR1-dependent phenotypic polarization [RNA-Seq]
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Microglia are strongly implicated in demyelinating neurodegenerative diseases with increasing evidence for roles in protection and healing, but the mechanisms that control CNS remyelination are poorly understood. Here we show that microglia-specific deletion of TNFR1 and pharmacological inhibition of soluble TNF (solTNF) or downstream IL-1R allow maturation of highly activated disease-associated microglia with increased size and myelin phagocytosis capacity that accelerate cortical remyelination and motor recovery. Single cell transcriptomic analysis of cortex at disease onset reveal that solTNF inhibition enhances reparative IL-10-responsive, while preventing damaging IL-1-related signatures of disease-associated microglia. Longitudinal brain transcriptome analysis through disease reveal earlier recovery upon therapeutic loss of microglia TNFR1. Functional relevance of microglia inflammatory polarization pathways for disease is validated in vivo. Furthermore, disease-state microglia producing downstream IL-1/IL-18/NLRP3/CASP1 targets are identified in human demyelinating lesions. Overall, redirecting disease microglia polarization by targeting cytokines is a potential approach for improving CNS repair in demyelinating disorders.
 
Overall design Brain transcriptome at hallmark disease timepoints of cuprizone demyelination and remyelination, and the effect of microglia TNFR1 deletion in remyelination, by whole brain RNA-Seq analysis from naïve (CPZ0; N), peak of demyelination (CPZ5; DM), and remyelination (CPZ6+1; RM) TNFR1ff controls (backcrossed onto C57BL/6) , and from remyelination mgTNFR1KO (CPZ6+1; RM-KO) (Cx3cr1-CreER.Tnfr1ff) mice after therapeutic tamoxifen-induced microglia-specific TNFR1 deletion. (n=7 samples/group)
 
Contributor(s) Boutou A, Roufagalas I, Politopoulou K, Tastsoglou S, Skoufos G, Hatzigeorgiou AG, Probert L
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Sep 26, 2024
Last update date Nov 13, 2024
Contact name Lesley Probert
E-mail(s) [email protected]
Organization name Hellenic Pasteur Institute
Department Immunology
Lab Molecular Genetics
Street address Vassilisis Sofias 127
City Athens
State/province Attiki
ZIP/Postal code 11521
Country Greece
 
Platforms (1)
GPL21626 NextSeq 550 (Mus musculus)
Samples (28)
GSM8540679 Whole brain, TNFR1ff, demyelination, rep1
GSM8540680 Whole brain, TNFR1ff, demyelination, rep2
GSM8540681 Whole brain, TNFR1ff, demyelination, rep3
Relations
BioProject PRJNA1165754

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE278137_RAW.tar 32.9 Mb (http)(custom) TAR (of RESULTS)
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap